Humanigen Inc (HGENQ)

[cowtown jay]

The topic that we heard of from Dale, far more so than from Durrant, dealt with how quickly our "commercial footprint" could be imprinted into the covid market.

That's going to take manufacturing capacity, and a commercial infrastructure. But I don't think, once we get an EUA or CMA, that we are then going to have to establish that capacity or infrastructure. I think we likely already have that established, based upon securing regulatory authorization or approval.